Latest Breaking News On - Simplify disc - Page 2 : vimarsana.com
Cervical Total Disc Replacement Market Estimated To Experience A Hike In Growth By 2031 – Kentucky Journal 24
kyn24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kyn24.com Daily Mail and Mail on Sunday newspapers.
Cervical Total Disc Replacement Market growth to spur with increasing innovations and inventions: Trends Market Research – Kentucky Journal 24
kyn24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kyn24.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
WASHINGTON, May 12, 2021 /PRNewswire/ MCRA, LLC, the leading privately held medical device and biologics advisory firm and Clinical Research Organization (CRO) integrating U.S. and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, Quality Assurance, and Medical Device Cybersecurity, is pleased to announce its role in the successful management and execution of Simplify Medical s two clinical studies and approvals by the U.S. Food and Drug Administration (FDA) for the Simplify Cervical Artificial Disc (Simplify Disc) to be used at one-level and two contiguous levels in the cervical spine.
Abigail Allen, MCRA s Vice President of Clinical Affairs, said, MCRA is honored to have supported Simplify Medical with the approval of their two-level disc just six months after the one-level approval. It has been a true testament to the teamwork and collaboration between the two companies, and all of our sites, to get the
Operator
Good day. And welcome to the NuVasive Inc. Fourth Quarter and Full Year 2020 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Matt Harbaugh, Executive Vice President and Chief Financial Officer. Thank you. You may begin.
Matt Harbaugh
Executive Vice President and Chief Financial Officer
Thank you. Welcome to NuVasive s Fourth Quarter and Full Year 2020 Earnings Call. The company s earnings release, which we issued earlier this afternoon, has been filed on Form 8-K with the Securities and Exchange Commission. We have also posted supplemental financial information and an overview on the acquisition of Simplify Medical we announced yesterday on our website in the Investor Relations section to accompany our discussion today. Joining me on the call is NuVasive S CEO, Chris Barry. Chris will provide opening remarks and then I will share additional details on our fi
NuVasive Announces First Quarter 2021 Financial Results Net sales increase driven by U.S. procedural volume improvement throughout the quarter and strong international growth Simplify Cervical Artificial Disc receives FDA approval for two-level cervical total disc replacement R&D investment increase year over year to advance spine procedural segments and enabling technology roadmap
News provided by
Share this article
Share this article
SAN DIEGO, May 5, 2021 /PRNewswire/ NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended March 31, 2021.
vimarsana © 2020. All Rights Reserved.